ライフサイエンスコーパス: arterial stiffness

1 Vo2 without altering endothelial function or arterial stiffness.

2 or carbohydrates on endothelial function and arterial stiffness.

3 ressure, forearm blood flow, or estimates of arterial stiffness.

4 flavones are inversely associated with lower arterial stiffness.

5 dial viability ratio were measured to assess arterial stiffness.

6 ve velocity-a clinically relevant measure of arterial stiffness.

7 om fish may improve endothelial function and arterial stiffness.

8 k-favorably affects endothelial function and arterial stiffness.

9 rtension, in part through kidney disease and arterial stiffness.

10 dial artery applanation tonometry to measure arterial stiffness.

11 ides information on both atherosclerosis and arterial stiffness.

12 asonography, and radial tonometry to measure arterial stiffness.

13 complex interaction between ventricular and arterial stiffness.

14 lations of several biomarkers to measures of arterial stiffness.

15 icular hypertrophy and evidence of increased arterial stiffness.

16 and radial applanation tonometry to measure arterial stiffness.

17 tact parathyroid hormone predicted increased arterial stiffness.

18 its hallmark abnormality: increased central arterial stiffness.

19 sfunction are also associated with increased arterial stiffness.

20 predict changes in central pulse pressure or arterial stiffness.

21 d noradrenaline increase aortic and systemic arterial stiffness.

22 lse pressure provides a surrogate measure of arterial stiffness.

23 ows assessment of central pulse pressure and arterial stiffness.

24 amber and myocardial function, and increased arterial stiffness.

25 ts of long-term magnesium supplementation on arterial stiffness.

26 may be assessed by determining the degree of arterial stiffness.

27 n pregnancy has lasting effects on offspring arterial stiffness.

28 ve better performance over AI r in assessing arterial stiffness.

29 althy postmenopausal women is beneficial for arterial stiffness.

30 etin-2 as a link between kidney fibrosis and arterial stiffness.

31 l approach to ameliorate atherosclerosis and arterial stiffness.

32 erial blood pressure, a surrogate marker for arterial stiffness.

33 genes regulate intrinsic SM tone and thereby arterial stiffness.

34 ivity in other conditions is associated with arterial stiffness, a marker of cardiovascular risk.

35 t of asymmetric dimethyl arginine in causing arterial stiffness, a phenomenon which has been linked w

36 With the exception of arterial stiffness, all these findings are opposite in d

37 ting serum lipids, microvascular reactivity, arterial stiffness, ambulatory blood pressure, and marke

38 inol ameliorates endothelial dysfunction and arterial stiffness among patients without chronic kidney

39 Two indirect measures of arterial stiffness, an ankle brachial index greater than

40 Arterial stiffness, an independent determinant of cardio

41 this relationship is unclear but may involve arterial stiffness, an independent risk marker for CVD m

42 ufficiency will be associated with increased arterial stiffness and abnormal vascular function.

43 Direct measures of arterial stiffness and atherosclerosis included central

44 Whole body insulin sensitivity, arterial stiffness and blood pressure were also assessed

45 umans have examined the relationship between arterial stiffness and blood pressure.

46 In adults, NAFLD is a determinant of arterial stiffness and cardiovascular risk, independent

47 t this novel approach significantly improves arterial stiffness and central hemodynamics, which might

48 significant treatment effects were noted for arterial stiffness and central mean or 24-h ambulatory b

49 the temporal relationship of elevated BP to arterial stiffness and elasticity.

50 D insufficiency is associated with increased arterial stiffness and endothelial dysfunction in the co

51 ensitivity, adipose tissue inflammation, and arterial stiffness and exerts a beneficial shift in gut

52 Increased arterial stiffness and higher plasma natriuretic peptide

53 Increased arterial stiffness and impaired endothelial function are

54 Arterial stiffness and impaired nitric oxide (NO) bioava

55 EECP treatment reduces arterial stiffness and improves wave reflection characte

56 Arterial stiffness and inflammation are associated with

57 pulse wave velocity (PWV) reflects increased arterial stiffness and is an established cardiovascular

58 Arterial stiffness and left ventricular hypertrophy may

59 Arterial stiffness and mean arterial pressure variably c

60 We studied the association between arterial stiffness and mild-to-moderate CKD and albuminu

61 ogenesis and maintenance of hypertension and arterial stiffness and more novel cardiovascular risk fa

62 of calibrated tonometry and pulsed Doppler, arterial stiffness and pulsatile hemodynamics were asses

63 uggest distinct polygenic susceptibility for arterial stiffness and salt-sensitive hypertension in Da

64 patients and looked for associations between arterial stiffness and SCD-related vascular complication

65 based studies have evaluated the genetics of arterial stiffness and separate mean and pulsatile compo

66 data for exercise training's improvement of arterial stiffness and system inflammation and reduction

67 These data, which include direct measures of arterial stiffness and thickness, suggest that higher in

68 The association between arterial stiffness and various cardiovascular outcomes (

69 Various measures of arterial stiffness and wave reflection have been propose

70 Increased arterial stiffness and wave reflections are present in m

71 se pressure (bPP), aoPP, and all measures of arterial stiffness and wave reflections were higher in H

72 sitive patients with AAV are associated with arterial stiffness and whether treatment with valaciclov

73 ed preload, and decreases in blood pressure, arterial stiffness, and afterload as well, thereby impro

74 It causes significant arterial stiffness, and as yet, no clinical therapy exis

75 e levels as well as markers of inflammation, arterial stiffness, and atherosclerosis.

76 ed by a forward pressure wave and related to arterial stiffness, and augmentation pressure (AP), thou

77 ted dilatation (FMD) of the brachial artery, arterial stiffness, and blood pressure.

78 Blood pressure, arterial stiffness, and endothelial function in the peri

79 opathy, cardiovascular autonomic neuropathy, arterial stiffness, and hypertension.

80 This cell population is associated with arterial stiffness, and its expansion is attenuated with

81 Associations between serum phosphate, arterial stiffness, and left ventricular (LV) mass sugge

82 icate that AASV is associated with increased arterial stiffness, and that stiffness correlates with t

83 nifedipine, and placebo on proteinuria, BP, arterial stiffness, and various cardiovascular biomarker

84 ative stress, high rates of hypertension and arterial stiffness; and those without constitutive expre

85 We prospectively measured arterial stiffness (aortic pulse wave velocity [aPWV]) a

86 (AIx), which provides a measure of systemic arterial stiffness, aortic stiffness and central arteria

87 LV systolic and arterial stiffness are increased, which may exacerbate l

88 Elevation in plasma ET-1 and increases in arterial stiffness are potential important mechanisms un

89 Increases in arterial stiffness are related to inflammation, and are

90 t gaps were female; P < 0.05), and increased arterial stiffness (arterial stiffness index, 8.5 4.6 in

91 her studies examining the potential value of arterial stiffness as a screening tool to guide initiati

92 s index and, in a subpopulation of patients, arterial stiffness as measured by pulse wave velocity.

93 also documented the prognostic importance of arterial stiffness (AS) in various populations as an ind

94 24 wk in overweight and obese adults reduces arterial stiffness, as estimated by a decrease in PWVc-f

95 associations with myocardial infarction and arterial stiffness, as well as coronary artery calcifica

96 orrelated independently with the severity of arterial stiffness assessed by pulse wave velocity.

97 ole of angiopoietin-2 in the pathogenesis of arterial stiffness associated with CKD.

98 This study compared indices of arterial stiffness at rest and during exercise in subjec

99 d whether this might reflect consequences of arterial stiffness, atherosclerosis, or both is unknown.

100 r system--platelet and endothelial function, arterial stiffness, atherosclerosis, oxidative stress, i

101 history of AF, liver/kidney transplantation, arterial stiffness, atherosclerotic plaques in the aorta

102 rom the lower body, resulting from increased arterial stiffness, augments central aortic pressure and

103 Second, effects on arterial stiffness, blood pressure, serum lipids, and pl

104 carotid intima-media thickness (a measure of arterial stiffness), brachial artery reactivity (both fl

105 trength-training does not lead to changes in arterial stiffness but to vascular remodeling.

106 unction by flow-mediated dilation (FMD), and arterial stiffness by applanation tonometry.

107 maging and echocardiography, and we assessed arterial stiffness by carotid-femoral pulse wave velocit

108 f the brachial artery, and evaluated central arterial stiffness by pulse-wave analysis.

109 ort a role for the endothelium in regulating arterial stiffness by release of vasoactive mediators.

110 ort a role for the endothelium in regulating arterial stiffness by release of vasoactive mediators.

111 function (primary outcome), blood pressure, arterial stiffness, cardiac autonomic function, platelet

112 cause of age-associated increases in central arterial stiffness, cardiovagal BRS was expressed with b

113 Arterial stiffness (carotid to femoral pulse wave veloci

114 sma lipids, glucose, C-reactive protein, and arterial stiffness [carotid-femoral pulse wave velocity

115 ual flavonoid intakes and direct measures of arterial stiffness, central blood pressure, and atherosc

116 ally improve central hemodynamics and reduce arterial stiffness compared with conventional beta-block

117 ive protein levels, homocysteine levels, and arterial stiffness compared with those without LV hypert

118 scular endothelial dysfunction and increased arterial stiffness contribute to increased cardiovascula

119 Arterial stiffness contributes to CVD risk in CKD.

120 In summary, arterial stiffness correlates with albuminuria but not w

121 Whether arterial stiffness correlates with mild-to-moderate CKD

122 Any gender differences in arterial stiffness could influence pulse pressure (PP),

123 ntation index (AIx) is a measure of systemic arterial stiffness derived from the ascending aortic pre

124 In cross-sectional analyses, arterial stiffness did not associate with CKD (defined b

125 y (2-8 repeated measures, median of 5), and arterial stiffness estimates of 3 large arteries (ultras

126 Arterial stiffness, flow-mediated dilation (FMD), nitrog

127 109 +/- 9 mmHg, P = 0.049) without impacting arterial stiffness, FMD, GMD, or NO.

128 king blood pressure and different aspects of arterial stiffness from childhood onward, with an aim of

129 , and magnetic resonance imaging, we related arterial stiffness, GFR, urinary albumin excretion, and

130 Recently, arterial stiffness has emerged as an independent risk fa

131 Because arterial stiffness has independent prognostic value for

132 of endothelin-1 (ET-1) in the regulation of arterial stiffness has not been investigated.

133 hip between elevated blood pressure (BP) and arterial stiffness in a biracial (black-white) cohort of

134 sease activity, endothelial dysfunction, and arterial stiffness in a cohort of rheumatoid arthritis (

135 adolescence to adulthood) is associated with arterial stiffness in adulthood.

136 id synthesis ameliorates atherosclerosis and arterial stiffness in apolipoprotein E(-/-) mice and rab

137 rs (ARBs) improves left ventricular mass and arterial stiffness in early-stage chronic kidney disease

138 e reduces left ventricular mass and improves arterial stiffness in early-stage CKD.

139 gents that target the NO pathway in reducing arterial stiffness in HFpEF.

140 to carotid atherosclerosis and to increased arterial stiffness in hypertensive patients, independent

141 (Predictive Values of Blood Pressure and Arterial Stiffness in Institutionalized Very Aged Popula

142 sociated with blood pressure and measures of arterial stiffness in nondemented individuals.

143 antigens, is quantitatively associated with arterial stiffness in older life.

144 medullin, and homocysteine concentrations to arterial stiffness in participants in the Framingham Hea

145 te the relationship between inflammation and arterial stiffness in patients with antineutrophil cytop

146 We assessed arterial stiffness in SCD patients and looked for associ

147 for quantitative trait loci (QTLs) affecting arterial stiffness in six-week old F2 (Dahl S x R)-inter

148 carbonate improves LV mass, LV function, or arterial stiffness in stage 3 nondiabetic CKD.

149 We assessed arterial stiffness in subjects with Sri Lankan CKDu, in

150 Whether cognition is influenced by arterial stiffness in the absence of vascular disease re

151 NAFLD is only associated with increased arterial stiffness in the presence of the "high risk" me

152 nthesis could ameliorate atherosclerosis and arterial stiffness in transgenic mice and rabbits.

153 This review summarizes the role of arterial stiffness in ventricular-vascular coupling in t

154 t nitric oxide (NO) acting locally regulates arterial stiffness in vivo, and the aim of this experime

155 or drugs on pulse pressure amplification and arterial stiffness in vivo.

156 dex and augmentation pressure, correlates of arterial stiffness, in a cohort of elderly men in the Bo

157 Arterial stiffness increased at 12 weeks compared with 3

158 Furthermore, because arterial stiffness increases left ventricular afterload,

159 Arterial stiffness increases with age and contributes to

160 Ventricular and arterial stiffness increases with age in both sexes, but

161 was to ascertain if NAFLD is associated with arterial stiffness, independent of cardiometabolic facto

162 The arterial stiffness index was correspondingly increased (

163 P < 0.05), and increased arterial stiffness (arterial stiffness index, 8.5 4.6 in patients with gaps

164 trast, ADMA was significantly related to the arterial stiffness index.

165 Central blood pressure and arterial stiffness indexes were measured at baseline and

166 deposition changes over time and generalized arterial stiffness indicated a relationship between the

167 Serial measurements of arterial stiffness indices [i.e., aortic pulse wave velo

168 y improved endothelium-dependent dilatation, arterial stiffness, intima media thickness and blood pre

169 the setting of diabetes mellitus, promoting arterial stiffness irrespective of calcification.

170 Arterial stiffness is a key determinant of cardiovascula

171 Arterial stiffness is an important determinant of cardio

172 Arterial stiffness is an important determinant of cardio

173 Future studies should evaluate whether arterial stiffness is an important mechanism leading to

174 Arterial stiffness is an important risk factor for cardi

175 Arterial stiffness is an independent predictor of cardio

176 Although arterial stiffness is believed to underlie, in part, the

177 Whether arterial stiffness is influenced by lifetime fiber intak

178 owever, the performance of AI r in assessing arterial stiffness is limited.

179 This study sought to demonstrate that arterial stiffness is probably underestimated in patient

180 with age in nondemented individuals and that arterial stiffness is strongly associated with the progr

181 wave velocity (PWV), a noninvasive index of arterial stiffness, is a predictor of the longitudinal c

182 ne whether pulse pressure (PP), a measure of arterial stiffness, is an independent predictor of the i

183 A high ABI, a marker of lower extremity arterial stiffness, is associated with CVD events and mo

184 ity-dwelling older adults, aPWV, a marker of arterial stiffness, is associated with higher CV mortali

185 reflections and PP amplification, but not of arterial stiffness, is observed when hypertension is stu

186 Arterial stiffness leads to LV mass through nonatheroscl

187 ion was evaluated by 24-hour blood pressure, arterial stiffness, low (LF)- and high (HF)-frequency he

188 pathophysiological processes that determine arterial stiffness may help guide therapeutic approaches

189 Endothelial function and arterial stiffness may therefore serve as important phys

190 Primary outcomes were 1) arterial stiffness measured by aortic pulse wave velocit

191 s of cardiovascular disease, suggesting that arterial stiffness, measured via carotid-femoral pulse w

192 ardiovascular evaluation, including imaging, arterial stiffness measurements, and biochemical studies

193 to examine the associations between baseline arterial stiffness measures (exposure variables) and inc

194 Arterial stiffness measures and mean and pulsatile compo

195 Arterial stiffness modulates ventricular loading conditi

196 Cardiovascular (24-h blood pressure, arterial stiffness), neurobehavioral (subjective sleepin

197 hange BP (office BP and 24-h ambulatory BP), arterial stiffness, nitric oxide, endothelin 1, or blood

198 o assess the effects of indirect measures of arterial stiffness on cognitive performance.

199 but no significant difference in the odds of arterial stiffness (OR, 1.07; 95% CI, 0.63-1.84; P = .80

200 patients, such as impaired vision, increased arterial stiffness, or decreased kidney function.

201 tation did not improve endothelial function, arterial stiffness, or inflammation.

202 vestigate the effects of oral astaxanthin on arterial stiffness, oxidative stress, and inflammation i

203 xanthin (12 mg/d for 12 mo) had no effect on arterial stiffness, oxidative stress, or inflammation in

204 s indicated that only female sex (P < 0.02), arterial stiffness (P < 0.002), and atherosclerotic plaq

205 d pressure variability (P = .01), peripheral arterial stiffness (P = .02), carotid intima-media thick

206 Furthermore, patients demonstrated higher arterial stiffness (P = 0.005), LF and HF heart rate var

207 ng SLE patients, LV mass was associated with arterial stiffness (P<0.001).

208 tients with coronary heart disease (CHD) and arterial stiffness progression in young healthy subjects

209 nificantly and independently associated with arterial stiffness progression, incident subclinical ath

210 Quantitation of central arterial stiffness provides a modest increment in cardio

211 ustment for clinical factors known to modify arterial stiffness, proximal thoracic aortic stiffness w

212 Measures of arterial stiffness (pulse wave velocity [PWV] and augmen

213 se pressure (cPP), their relation to central arterial stiffness (pulse wave velocity [PWV]) and arter

214 na, heart failure, or stroke) in relation to arterial stiffness (pulse wave velocity [PWV]), wave ref

215 (laser Doppler imaging with iontophoresis), arterial stiffness (pulse wave velocity and analysis), b

216 monitor), renin and aldosterone levels, and arterial stiffness (pulse wave velocity and augmentation

217 Measures of arterial stiffness (pulse wave velocity and augmentation

218 icular mass (cardiac magnetic resonance) and arterial stiffness (pulse wave velocity/analysis, aortic

219 an 8.2 +/- 3.2% vs. 8.1 +/- 3.3%), and lower arterial stiffness (pulse wave velocity: mean 6.99 +/- 1

220 (laser Doppler imaging with iontophoresis), arterial stiffness [pulse wave velocity, pulse wave anal

221 None of these arterial stiffness QTLs co-localized with previously rep

222 A demonstrated comparable relationships with arterial stiffness (r(2) = 0.616 for homocysteine and r(

223 increased flow-mediated dilatation, reduced arterial stiffness, reduced mean arterial and diastolic

224 This suggests that arterial stiffness related to the presence of NAFLD is p

225 function, with increases in small and large arterial stiffness representing a characteristic change

226 bation frequency was related to stable-state arterial stiffness (rho = 0.209; P = 0.040).

227 Arterial stiffness rises acutely during COPD exacerbatio

228 Arterial stiffness rose by an average of 1.2 ms(-1) (11.

229 ular disease, factors capable of influencing arterial stiffness, such as exercise and the use of reni

230 than those with CRI (P < 0.001) and greater arterial stiffness than both CRI patients and control su

231 Frequent COPD exacerbators have greater arterial stiffness than infrequent exacerbators.

232 evalence of left ventricular hypertrophy and arterial stiffness that confer an adverse prognosis.

233 ce imaging assessment of cardiac morphology, arterial stiffness (total aortic compliance and arterial

234 In a subsample (n = 42), cPP, arterial stiffness (using pulse wave velocity [PWV]) and

235 osclerosis is, in part, related to increased arterial stiffness, vascular dysfunction, elevated oxida

236 greater insight into hemodynamics of altered arterial stiffness versus impaired peripheral resistance

237 absence of other factors known to influence arterial stiffness was assessed.

238 Arterial stiffness was determined by pulse-wave velocity

239 To look at effects on subclinical disease, arterial stiffness was evaluated at baseline and after 5

240 Arterial stiffness was increased in ExDHF dogs.

241 Arterial stiffness was measured with a noninvasive and a

242 Pulse wave velocity (index of arterial stiffness) was also increased.

243 n of arterial pulse pressure (a surrogate of arterial stiffness) was linked to deterioration of the w

244 duction in pulse-wave velocity, a measure of arterial stiffness, was associated with a decrease in AD

245 Pulse pressure/stroke volume, a measure of arterial stiffness, was higher in participants with DM (

246 2 peak ), whole body insulin sensitivity and arterial stiffness were also assessed.

247 Blood pressure, weight, and arterial stiffness were also measured.

248 Moreover, lipid concentrations and arterial stiffness were also unaffected by the intervent

249 and radial applanation tonometry to measure arterial stiffness were evaluated in SLE patients.

250 tress markers (glutathione and cystine), and arterial stiffness were evaluated.

251 T or BP, clinically relevant improvements in arterial stiffness were observed; equol producers were p

252 The measures of arterial stiffness were the carotid femoral pulse wave v

253 gether with augmentation index, a measure of arterial stiffness, were determined before and at interv

254 echniques for estimating the many aspects of arterial stiffness which are not fully understood.

255 Arterial stiffness, which is a measure of arterial aging

256 igate the association of local and segmental arterial stiffness with incident cardiovascular events a

257 derives performance improvement in assessing arterial stiffness, with a stronger correlation with cfP

258 elected nucleotide excision repair genes and arterial stiffness within the AortaGen Consortium and fo